US Broker Ratings

Ionis Pharmaceuticals (IONS) Stock Analysis: Uncovering a Potential 62% Upside in the Biotech Sector

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands as a notable player in the biotechnology sector, attracting investor attention with its innovative RNA-targeted medicines and collaborations with major pharmaceutical entities. With a..

Prestige Consumer Healthcare (PBH) Stock Analysis: Uncovering a 34.51% Potential Upside

Prestige Consumer Healthcare Inc. (NASDAQ: PBH) stands as a notable player in the healthcare sector, specializing in the development and distribution of over-the-counter health and personal care products. With a..

Alkermes plc (ALKS) Stock Analysis: Robust Revenue Growth Amidst Strategic Expansion

Alkermes plc (NASDAQ: ALKS), an innovative player in the healthcare sector, is making significant strides in the drug manufacturing industry, particularly in specialty and generic drugs. With its headquarters in..

RadNet, Inc. (RDNT) Stock Analysis: A 45.77% Upside Potential in the Booming Diagnostics Sector

RadNet, Inc. (NASDAQ: RDNT), a leading player in the Healthcare sector, particularly within Diagnostics & Research, is attracting significant investor interest with an impressive market cap of $4.84 billion. Known..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 62% Upside Potential

iRhythm Holdings, Inc. (NASDAQ: IRTC), a pioneer in the healthcare sector, continues to capture investor interest with its innovative approach to cardiac monitoring. Headquartered in San Francisco, California, iRhythm specializes..

Integer Holdings Corporation (ITGR)

⚠️ No article content returned.

..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 7.17% Potential Upside in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a notable player in the healthcare sector, has been capturing investor attention with its strong position in the drug manufacturing industry, specifically in specialty and..

Ascendis Pharma A/S (ASND) Stock Analysis: Strong Buy Ratings Signal a Promising 20.23% Upside

Ascendis Pharma A/S (NASDAQ: ASND) is gaining momentum in the biotechnology sector, capturing the attention of investors with its innovative approach to addressing unmet medical needs. Based in Hellerup, Denmark,..

Baxter International Inc. (BAX) Stock Analysis: Navigating a Healthcare Giant’s Challenges and Opportunities

Baxter International Inc. (NYSE: BAX) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $11.57 billion, this..

AptarGroup, Inc. (ATR) Stock Analysis: Healthcare Innovator with a 24.98% Potential Upside

AptarGroup, Inc. (NYSE: ATR), a leader in the healthcare sector, is making waves with its innovative solutions for drug delivery and consumer product dispensing. With a market cap of $8.45..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating Volatility in Healthcare Innovation

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is making waves in the healthcare sector, specifically within the niche of traditional Chinese medicine (TCM). With a market capitalization of $2.83 billion, this..

Bio-Techne Corp (TECH) Investor Outlook: Evaluating its Steady Path in Biotechnology with a Focus on Stability

Bio-Techne Corp (NASDAQ: TECH) stands as a significant player in the biotechnology space, boasting a market cap of $11.16 billion. Known for developing and manufacturing life science reagents, instruments, and..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Biotechnology Innovator with Strong Buy Ratings and Upside Potential

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the healthcare sector, specifically within the biotechnology industry, with its innovative approach to precision oncology. Headquartered in Redwood City, California, this..

Tempus AI, Inc. (TEM) Stock Analysis: Exploring the 55.94% Potential Upside and Analyst Ratings

As Tempus AI, Inc. (NASDAQ: TEM) continues to innovate in the healthcare technology arena, individual investors are keenly evaluating its potential as an investment. With a market capitalization of $7.69..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Giant Poised for 25.90% Upside

The Ensign Group, Inc. (NASDAQ: ENSG), a major player in the healthcare sector with a market capitalization of $10.11 billion, is capturing investor attention with its substantial growth potential. Trading..

Stevanato Group S.p.A. (STVN) Stock Analysis: A Healthcare Giant with a 24.24% Upside Potential

For investors seeking exposure in the healthcare sector, Stevanato Group S.p.A. (NYSE: STVN) presents a compelling opportunity. With its broad range of products and services catering to the biopharma and..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring a 117.58% Potential Upside in Biotech

Atrium Therapeutics, Inc. (NASDAQ: RNA), a promising player in the biotechnology sector, is capturing investor attention with its significant potential upside, pegged at 117.58%. Specializing in RNA therapeutics aimed at..

Elanco Animal Health (ELAN) Stock Analysis: Uncovering a 20.72% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a key player in the healthcare sector, specifically within the drug manufacturing space for specialty and generic products, has been making waves with its..

Vaxcyte, Inc. (PCVX) Stock Analysis: A 99% Potential Upside in a Clinical-Stage Vaccine Innovator

Investors with an eye on the biotechnology sector may find Vaxcyte, Inc. (NASDAQ: PCVX) an intriguing opportunity, particularly with analysts projecting a potential upside of nearly 100%. As a clinical-stage..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Growth and Volatility in the Genomics Sector

As a prominent player in the genomics sector, Illumina, Inc. (NASDAQ: ILMN) has carved out a significant niche with its cutting-edge sequencing and array-based solutions. For investors, the company offers..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds